{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,3]],"date-time":"2026-05-03T14:49:08Z","timestamp":1777819748259,"version":"3.51.4"},"reference-count":58,"publisher":"International Society of Endovascular Specialists","issue":"SupplementI","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Endovascular Therapy"],"published-print":{"date-parts":[[2009,2]]},"DOI":"10.1583\/08-2593.1","type":"journal-article","created":{"date-parts":[[2009,6,1]],"date-time":"2009-06-01T12:45:29Z","timestamp":1243860329000},"page":"I-153-I-162","source":"Crossref","is-referenced-by-count":9,"title":["Infrapopliteal Stents:\n                    <b>Overview and Unresolved Issues<\/b>"],"prefix":"10.1583","volume":"16","author":[{"given":"Dimitris","family":"Karnabatidis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Konstantinos","family":"Katsanos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dimitris","family":"Siablis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"527","reference":[{"key":"i1545-1550-16-SupplementI-153-b1","doi-asserted-by":"crossref","unstructured":"J. C. Palmaz, Intravascular stents in the last and the next 10 years., J Endovasc Ther, 2004 .11 :(Suppl II).II-200 \u2013II-206 .","DOI":"10.1583\/04-1363.1"},{"key":"i1545-1550-16-SupplementI-153-b2","doi-asserted-by":"crossref","unstructured":"J. H. Rogers, and J. R. Laird .Overview of new technologies for lower extremity revascularization., Circulation, 2007 .116 :2072 \u20132085 .","DOI":"10.1161\/CIRCULATIONAHA.107.715433"},{"key":"i1545-1550-16-SupplementI-153-b3","doi-asserted-by":"crossref","unstructured":"S. H. Duda, T. C. Poerner, and B. Wiesinger .et al.Drug-eluting stents: potential applications for peripheral arterial occlusive disease., J Vasc Interv Radiol, 2003 .14 :291 \u2013301 .","DOI":"10.1097\/01.RVI.0000058423.01661.57"},{"key":"i1545-1550-16-SupplementI-153-b4","doi-asserted-by":"crossref","unstructured":"A. T. Ong, and P. W. Serruys .Technology Insight: an overview of research in drug-eluting stents., Nat Clin Pract Cardiovasc Med, 2005 .2 :647 \u2013658 .","DOI":"10.1038\/ncpcardio0378"},{"key":"i1545-1550-16-SupplementI-153-b5","doi-asserted-by":"crossref","unstructured":"P. W. Serruys, M. J. Kutryk, and A. T. Ong .Coronary-artery stents., N Engl J Med, 2006 .354 :483 \u2013495 .","DOI":"10.1056\/NEJMra051091"},{"key":"i1545-1550-16-SupplementI-153-b6","doi-asserted-by":"crossref","unstructured":"G. Dorros, M. R. Jaff, and K. J. Murphy .et al.The acute outcome of tibioperoneal vessel angioplasty in 417 cases with claudication and critical limb ischemia., Cathet Cardiovasc Diagn, 1998 .45 :251 \u2013256 .","DOI":"10.1002\/(SICI)1097-0304(199811)45:3<251::AID-CCD7>3.0.CO;2-E"},{"key":"i1545-1550-16-SupplementI-153-b7","doi-asserted-by":"crossref","unstructured":"S. Rastogi, and S. W. Stavropoulos .Infrapopliteal angioplasty., Tech Vasc Interv Radiol, 2004 .7 :33 \u201339 .","DOI":"10.1053\/j.tvir.2004.01.001"},{"key":"i1545-1550-16-SupplementI-153-b8","doi-asserted-by":"crossref","unstructured":"D. J. Spinosa, D. A. Leung, and A. H. Matsumoto .et al.Percutaneous intentional extraluminal recanalization in patients with chronic critical limb ischemia., Radiology, 2004 .232 :499 \u2013507 .","DOI":"10.1148\/radiol.2322030729"},{"key":"i1545-1550-16-SupplementI-153-b9","doi-asserted-by":"crossref","unstructured":"D. Tsetis, and A. M. Belli .The role of infrapopliteal angioplasty., Br J Radiol, 2004 .77 :1007 \u20131015 .","DOI":"10.1259\/bjr\/97382129"},{"key":"i1545-1550-16-SupplementI-153-b10","doi-asserted-by":"crossref","unstructured":"J. H. Wolfe, and M. G. Wyatt .Critical and subcritical ischaemia., Eur J Vasc Endovasc Surg, 1997 .13 :578 \u2013582 .","DOI":"10.1016\/S1078-5884(97)80067-6"},{"key":"i1545-1550-16-SupplementI-153-b11","doi-asserted-by":"publisher","DOI":"10.1583\/05-1620MR.1"},{"key":"i1545-1550-16-SupplementI-153-b12","doi-asserted-by":"crossref","unstructured":"M. Bosiers, J. P. Hart, and K. Deloose .et al.Endovascular therapy as the primary approach for limb salvage in patients with critical limb ischemia: experience with 443 infrapopliteal procedures., Vascular, 2006 .14 :63 \u201369 .","DOI":"10.2310\/6670.2006.00014"},{"key":"i1545-1550-16-SupplementI-153-b13","doi-asserted-by":"crossref","unstructured":"H. Krankenberg, I. Sorge, and T. Zeller .et al.Percutaneous transluminal angioplasty of infrapopliteal arteries in patients with intermittent claudication: acute and one-year results., Catheter Cardiovasc Interv, 2005 .64 :12 \u201317 .","DOI":"10.1002\/ccd.20237"},{"key":"i1545-1550-16-SupplementI-153-b14","doi-asserted-by":"crossref","unstructured":"M. G. Davies, W. E. Saad, and E. K. Peden .et al.Impact of runoff on superficial femoral artery endoluminal interventions for rest pain and tissue loss., J Vasc Surg, 2008 .48 :619 \u2013626 .","DOI":"10.1016\/j.jvs.2008.04.013"},{"key":"i1545-1550-16-SupplementI-153-b15","unstructured":"L. A. Fleisher, J. A. Beckman, and K. A. Brown .et al.ACC\/AHA 2006 guideline update on perioperative cardiovascular evaluation for noncardiac surgery: focused update on perioperative beta-blocker therapy: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2002 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery) developed in collaboration with the American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Rhythm Society, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society for Vascular Medicine and Biology., J Am Coll Cardiol, 2006 .47 :2343 \u20132355 ."},{"key":"i1545-1550-16-SupplementI-153-b16","doi-asserted-by":"crossref","unstructured":"W. Horvath, M. Oertl, and D. Haidinger .Percutaneous transluminal angioplasty of crural arteries., Radiology, 1990 .177 :565 \u2013569 .","DOI":"10.1148\/radiology.177.2.2145609"},{"key":"i1545-1550-16-SupplementI-153-b18","doi-asserted-by":"crossref","unstructured":"K. Kandarpa, G. J. Becker, and M. G. Hunink .et al.Transcatheter interventions for the treatment of peripheral atherosclerotic lesions: part I., J Vasc Interv Radiol, 2001 .12 :683 \u2013695 .","DOI":"10.1016\/S1051-0443(07)61438-9"},{"key":"i1545-1550-16-SupplementI-153-b19","doi-asserted-by":"crossref","unstructured":"M. Romiti, M. Albers, and F. C. Brochado-Neto .et al.Meta-analysis of infrapopliteal angioplasty for chronic critical limb ischemia., J Vasc Surg, 2008 .47 :975 \u2013981 .","DOI":"10.1016\/j.jvs.2008.01.005"},{"key":"i1545-1550-16-SupplementI-153-b20","doi-asserted-by":"crossref","unstructured":"J. L. Ballard, and J. L. Mills .Surgical management of critical limb ischemia., Tech Vasc Interv Radiol, 2005 .8 :169 \u2013174 .","DOI":"10.1053\/j.tvir.2006.04.004"},{"key":"i1545-1550-16-SupplementI-153-b21","doi-asserted-by":"crossref","unstructured":"D. K. Chew, M. S. Conte, and M. C. Donaldson .et al.Autogenous composite vein bypass graft for infrainguinal arterial reconstruction., J Vasc Surg, 2001 .33 :259 \u2013265 .","DOI":"10.1067\/mva.2001.112699"},{"key":"i1545-1550-16-SupplementI-153-b22","doi-asserted-by":"crossref","unstructured":"P. L. Faries, S. Arora, and F. B. Pomposelli .et al.The use of arm vein in lower-extremity revascularization: results of 520 procedures performed in eight years., J Vasc Surg, 2000 .31 :50 \u201359 .","DOI":"10.1016\/S0741-5214(00)70067-X"},{"key":"i1545-1550-16-SupplementI-153-b23","doi-asserted-by":"crossref","unstructured":"B. G. Halloran, M. P. Lilly, and E. J. Cohn .et al.Tibial bypass using complex autologous conduit:patency and limb salvage., Ann Vasc Surg, 2001 .15 :634 \u2013643 .","DOI":"10.1007\/s10016-001-0090-z"},{"key":"i1545-1550-16-SupplementI-153-b24","doi-asserted-by":"crossref","unstructured":"M. Schillinger, M. Exner, and W. Mlekusch .et al.Endovascular revascularization below the knee: 6-month results and predictive value of C-reactive protein level., Radiology, 2003 .227 :419 \u2013425 .","DOI":"10.1148\/radiol.2272020137"},{"key":"i1545-1550-16-SupplementI-153-b25","doi-asserted-by":"crossref","unstructured":"G. Ansel, N. Sample, and C. J. Botti .et al.Cutting balloon angioplasty of the popliteal and infrapopliteal vessels for symptomatic limb ischemia., Catheter Cardiovasc Interv, 2004 .61 :1 \u20134 .","DOI":"10.1002\/ccd.10731"},{"key":"i1545-1550-16-SupplementI-153-b26","doi-asserted-by":"crossref","unstructured":"P. Peeters, M. Bosiers, and J. Verbist .et al.Preliminary results after application of absorbable metal stents in patients with critical limb ischemia., J Endovasc Ther, 2005 .12 :1 \u20135 .","DOI":"10.1583\/04-1349R.1"},{"key":"i1545-1550-16-SupplementI-153-b27","doi-asserted-by":"crossref","unstructured":"G. Dorros, P. Hall, and C. Prince .Successful limb salvage after recanalization of an occluded infrapopliteal artery utilizing a balloon expandable (Palmaz-Schatz) stent., Cathet Cardiovasc Diagn, 1993 .28 :83 \u201388 .","DOI":"10.1002\/ccd.1810280117"},{"key":"i1545-1550-16-SupplementI-153-b28","doi-asserted-by":"crossref","unstructured":"A. J. Feiring, A. A. Wesolowski, and S. Lade .Primary stent-supported angioplasty for treatment of below-knee critical limb ischemia and severe claudication: early and one-year outcomes., J Am Coll Cardiol, 2004 .44 :2307 \u20132314 .","DOI":"10.1016\/j.jacc.2004.09.037"},{"key":"i1545-1550-16-SupplementI-153-b29","doi-asserted-by":"crossref","unstructured":"T. Rand, A. Basile, and M. Cejna .et al.PTA versus carbofilm-coated stents in infrapopliteal arteries: pilot study., Cardiovasc Intervent Radiol, 2006 .29 :29 \u201338 .","DOI":"10.1007\/s00270-005-0276-9"},{"key":"i1545-1550-16-SupplementI-153-b31","doi-asserted-by":"crossref","unstructured":"D. Siablis, D. Karnabatidis, and K. Katsanos .et al.Infrapopliteal application of paclitaxel-eluting stents for critical limb ischemia: midterm angiographic and clinical results., J Vasc Interv Radiol, 2007 .18 :1351 \u20131361 .","DOI":"10.1016\/j.jvir.2007.07.018"},{"key":"i1545-1550-16-SupplementI-153-b32","unstructured":"D. Scheinert, M. Ulrich, and S. Scheinert .et al.Comparison of sirolimus-eluting vs bare-metal stents for the treatment of infrapopliteal obstructions., Eurointervention, 2006 .2 :169 \u2013174 ."},{"key":"i1545-1550-16-SupplementI-153-b33","doi-asserted-by":"publisher","DOI":"10.1583\/1545-1550(2007)14[241:SVBSAS]2.0.CO;2"},{"key":"i1545-1550-16-SupplementI-153-b34","doi-asserted-by":"crossref","unstructured":"J. R. Sindermann, V. Verin, and J. W. Hopewell .et al.Biological aspects of radiation and drug-eluting stents for the prevention of restenosis., Cardiovasc Res, 2004 .63 :22 \u201330 .","DOI":"10.1016\/j.cardiores.2004.02.001"},{"key":"i1545-1550-16-SupplementI-153-b35","doi-asserted-by":"crossref","unstructured":"R. Gallo, A. Padurean, and T. Jayaraman .et al.Inhibition of intimal thickening after balloon angioplasty in porcine coronary arteries by targeting regulators of the cell cycle., Circulation, 1999 .99 :2164 \u20132170 .","DOI":"10.1161\/01.CIR.99.16.2164"},{"key":"i1545-1550-16-SupplementI-153-b36","doi-asserted-by":"crossref","unstructured":"S. O. Marx, T. Jayaraman, and L. O. Go .et al.Rapamycin-FKBP inhibits cell cycle regulators of proliferation in vascular smooth muscle cells., Circ Res, 1995 .76 :412 \u2013417 .","DOI":"10.1161\/01.RES.76.3.412"},{"key":"i1545-1550-16-SupplementI-153-b37","doi-asserted-by":"crossref","unstructured":"M. Roque, E. D. Reis, and C. Cordon-Cardo .et al.Effect of p27 deficiency and rapamycin on intimal hyperplasia: in vivo and in vitro studies using a p27 knockout mouse model., Lab Invest, 2001 .81 :895 \u2013903 .","DOI":"10.1038\/labinvest.3780298"},{"key":"i1545-1550-16-SupplementI-153-b38","doi-asserted-by":"crossref","unstructured":"T. Suzuki, G. Kopia, and S. Hayashi .et al.Stent-based delivery of sirolimus reduces neointimal formation in a porcine coronary model., Circulation, 2001 .104 :1188 \u20131193 .","DOI":"10.1161\/hc3601.093987"},{"key":"i1545-1550-16-SupplementI-153-b39","doi-asserted-by":"crossref","unstructured":"M. C. Morice, P. W. Serruys, and J. E. Sousa .et al.A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization., N Engl J Med, 2002 .346 :1773 \u20131780 .","DOI":"10.1056\/NEJMoa012843"},{"key":"i1545-1550-16-SupplementI-153-b40","doi-asserted-by":"crossref","unstructured":"J. W. Moses, M. B. Leon, and J. J. Popma .et al.Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery., N Engl J Med, 2003 .349 :1315 \u20131323 .","DOI":"10.1056\/NEJMoa035071"},{"key":"i1545-1550-16-SupplementI-153-b41","doi-asserted-by":"crossref","unstructured":"J. Schofer, M. Schluter, and A. H. Gershlick .et al.Sirolimus-eluting stents for treatment of patients with long atherosclerotic lesions in small coronary arteries: double-blind, randomised controlled trial (E-SIRIUS)., Lancet, 2003 .362 :1093 \u20131099 .","DOI":"10.1016\/S0140-6736(03)14462-5"},{"key":"i1545-1550-16-SupplementI-153-b42","doi-asserted-by":"crossref","unstructured":"J. E. Sousa, M. A. Costa, and A. C. Abizaid .et al.Sustained suppression of neointimal proliferation by sirolimus-eluting stents: one-year angiographic and intravascular ultrasound follow-up., Circulation, 2001 .104 :2007 \u20132011 .","DOI":"10.1161\/hc4201.098056"},{"key":"i1545-1550-16-SupplementI-153-b43","unstructured":"M. Bosiers, K. Deloose, and J. Verbist .et al.Percutaneous transluminal angioplasty for treatment of \u201cbelow-the-knee\u201d critical limb ischemia: early outcomes following the use of sirolimus-eluting stents., J Cardiovasc Surg (Torino), 2006 .47 :171 \u2013176 ."},{"key":"i1545-1550-16-SupplementI-153-b44","doi-asserted-by":"crossref","unstructured":"P. Commeau, P. Barragan, and P. O. Roquebert .Sirolimus for below the knee lesions: mid-term results of SiroBTK study., Catheter Cardiovasc Interv, 2006 .68 :793 \u2013798 .","DOI":"10.1002\/ccd.20893"},{"key":"i1545-1550-16-SupplementI-153-b46","unstructured":"D. Scheinert, Update: drug-eluting stents in tibial arteries., Endovasc Today, 2007 .8 :71 \u201374 ."},{"key":"i1545-1550-16-SupplementI-153-b47","doi-asserted-by":"crossref","unstructured":"A. G. Grant, C. J. White, and T. J. Collins .et al.Infrapopliteal drug-eluting stents for chronic limb ischemia., Catheter Cardiovasc Interv, 2008 .71 :108 \u2013111 .","DOI":"10.1002\/ccd.21367"},{"key":"i1545-1550-16-SupplementI-153-b48","doi-asserted-by":"crossref","unstructured":"O. R. Rosales, S. Mathewkutty, and C. Gnaim .Drug eluting stents for below the knee lesions in patients with critical limb ischemia: long-term follow-up., Catheter Cardiovasc Interv, 2008 .72 :112 \u2013115 .","DOI":"10.1002\/ccd.21557"},{"key":"i1545-1550-16-SupplementI-153-b49","doi-asserted-by":"crossref","unstructured":"R. A. Hill, A. Boland, and R. Dickson .et al.Drug-eluting stents: a systematic review and economic evaluation., Health Technol Assess, 2007 .11 :iiixi \u2013221 .","DOI":"10.3310\/hta11460"},{"key":"i1545-1550-16-SupplementI-153-b50","doi-asserted-by":"crossref","unstructured":"C. Stettler, S. Allemann, and S. Wandel .et al.Drug eluting and bare metal stents in people with and without diabetes: collaborative network meta-analysis., BMJ, 2008 .337 :a1331 .","DOI":"10.1136\/bmj.a1331"},{"key":"i1545-1550-16-SupplementI-153-b51","doi-asserted-by":"crossref","unstructured":"G. G. Biondi-Zoccai, C. Moretti, and M. Lotrionte .et al.Safety of drug-coated stents., Expert Opin Drug Saf, 2008 .7 :597 \u2013606 .","DOI":"10.1517\/14740338.7.5.597"},{"key":"i1545-1550-16-SupplementI-153-b52","doi-asserted-by":"crossref","unstructured":"D. Scheinert, S. Scheinert, and J. Sax .et al.Prevalence and clinical impact of stent fractures after femoropopliteal stenting., J Am Coll Cardiol, 2005 .45 :312 \u2013315 .","DOI":"10.1016\/j.jacc.2004.11.026"},{"key":"i1545-1550-16-SupplementI-153-b53","doi-asserted-by":"crossref","unstructured":"D. Karnabatidis, K. Katsanos, and S. Spiliopoulos .et al.Incidence, anatomical location and clinical significance of compressions and fractures of infrapopliteal balloon-expandable metal stents., J Endovasc Ther, 2009 .16 :00 \u201300 .","DOI":"10.1583\/08-2530.1"},{"key":"i1545-1550-16-SupplementI-153-b54","doi-asserted-by":"crossref","unstructured":"L. Graziani, A. Silvestro, and V. Bertone .et al.Vascular involvement in diabetic subjects with ischemic foot ulcer: a new morphologic categorization of disease severity., Eur J Vasc Endovasc Surg, 2007 .33 :453 \u2013460 .","DOI":"10.1016\/j.ejvs.2006.11.022"},{"key":"i1545-1550-16-SupplementI-153-b55","doi-asserted-by":"crossref","unstructured":"R. Kickuth, H. H. Keo, and J. Triller .et al.Initial clinical experience with the 4-F self-expanding XPERT stent system for infrapopliteal treatment of patients with severe claudication and critical limb ischemia., J Vasc Interv Radiol, 2007 .18 :703 \u2013708 .","DOI":"10.1016\/j.jvir.2007.03.012"},{"key":"i1545-1550-16-SupplementI-153-b56","doi-asserted-by":"crossref","unstructured":"J. H. Peregrin, S. Smirova, and B. Koznar .et al.Self-expandable stent placement in infrapopliteal arteries after unsuccessful angioplasty failure: one-year follow-up., Cardiovasc Intervent Radiol, 2008 .31 :860 \u2013864 .","DOI":"10.1007\/s00270-007-9292-2"},{"key":"i1545-1550-16-SupplementI-153-b57","doi-asserted-by":"crossref","unstructured":"G. Tepe, T. Zeller, and S. Heller .et al.Self-expanding nitinol stents for treatment of infragenicular arteries following unsuccessful balloon angioplasty., Eur Radiol, 2007 .17 :2088 \u20132095 .","DOI":"10.1007\/s00330-006-0526-5"},{"key":"i1545-1550-16-SupplementI-153-b58","doi-asserted-by":"crossref","unstructured":"P. Erne, M. Schier, and T. J. Resink .The road to bioabsorbable stents: reaching clinical reality? Cardiovasc Intervent Radiol, 2006 .29 :11 \u201316 .","DOI":"10.1007\/s00270-004-0341-9"},{"key":"i1545-1550-16-SupplementI-153-b59","doi-asserted-by":"crossref","unstructured":"P. J. Geraghty, Bioabsorbable stenting for peripheral arterial occlusive disease., Perspect Vasc Surg Endovasc Ther, 2006 .18 :295 \u2013298 .","DOI":"10.1177\/1531003506297195"},{"key":"i1545-1550-16-SupplementI-153-b61","doi-asserted-by":"crossref","unstructured":"R. Erbel, C. Di Mario, and J. Bartunek .et al.Temporary scaffolding of coronary arteries with bioabsorbable magnesium stents: a prospective, non-randomised multicentre trial., Lancet, 2007 .369 :1869 \u20131875 .","DOI":"10.1016\/S0140-6736(07)60853-8"},{"key":"i1545-1550-16-SupplementI-153-b62","doi-asserted-by":"crossref","unstructured":"J. A. Ormiston, P. W. Serruys, and E. Regar .et al.A bioabsorbable everolimus-eluting coronary stent system for patients with single de-novo coronary artery lesions (ABSORB): a prospective open-label trial., Lancet, 2008 .371 :899 \u2013907 .","DOI":"10.1016\/S0140-6736(08)60415-8"}],"container-title":["Journal of Endovascular Therapy"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T21:29:01Z","timestamp":1777498141000},"score":1,"resource":{"primary":{"URL":"http:\/\/jet.sagepub.com\/lookup\/doi\/10.1583\/08-2593.1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,2]]},"references-count":58,"journal-issue":{"issue":"SupplementI","published-print":{"date-parts":[[2009,2]]}},"alternative-id":["10.1583\/08-2593.1"],"URL":"https:\/\/doi.org\/10.1583\/08-2593.1","relation":{},"ISSN":["1526-6028","1545-1550"],"issn-type":[{"value":"1526-6028","type":"print"},{"value":"1545-1550","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,2]]}}}